UPDATE 3-Immunomedics soars as lupus drug shows promise | Reuters
Links shared publicly online about this topic.
- 1,792total visits
UPDATE 3-Immunomedics soars as lupus drug shows promise | Reuters
* Positive Phase IIb results for UCB, Immunomedics drug * Treatment advantage of epratuzumab vs placebo 24.9 pct * Analysts say result promising but drug still high risk * Immunomedics shares up
View full resource at reuters.com
Most Recently Shared on August 27, 2009 at 3:44 pm By:
Immunomedics lupus drug shows promise; Positive Phase IIb results for epratuzumab http://ow.ly/lyNt
UPDATE 3-Immunomedics soars as lupus drug shows promise | Reuters
reuters.com — “* Positive Phase IIb results for UCB, Immunomedics drug * Treatment advantage of epratuzumab vs placebo 24.9 pct * Analysts say result promising but drug still high risk * Immunomedics shares up” View full resource at reuters.com
Most Recently Shared on August 27, 2009 at 8:25 am By:
Ben Hirschler Health Communicator
UCB and Immunomedics clear Phase II lupus hurdle - but can they repeat Human Genome's Phase III success? http://tinyurl.com/kuyzw6
Advertisement
